Ledger.Open graph →
SEC Form D · Amendment · filed May 9, 2023

Clover Biopharmaceuticals, Ltd

Offering
—
Sold
$48.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SHANGHAI, Israel
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Xiaodong Wang · Yarrow Point, WADirectorJoshua Liang · Chengdu, IsraelExec · DirectorPeng Liang · Chengdu, IsraelExec · Director · PromoterToru Ihara · Kanagawa, M0Exec · Director · PromoterWilliam W. Cagney · Luxembourg, LuxembourgExec · DirectorChristophe W. Lentschat · Luxembourg, LuxembourgDirectorJ. T. David · Amarillo, TXDirectorKeisha M. Dawson · Amarillo, TXExec · DirectorFaye P. Mcgrath · Berkeley, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗